BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9051068)

  • 1. Intraoperative phototherapy: a comparative study of intravenous and topical photofrin II and aminolevulinic acid.
    Davis RK; Straight R; Sun Y
    Otolaryngol Head Neck Surg; 1997 Feb; 116(2):223-7. PubMed ID: 9051068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole bladder photodynamic therapy for orthotopic superficial bladder cancer in rats: a study of intravenous and intravesical administration of photosensitizers.
    Xiao Z; Brown K; Tulip J; Moore RB
    J Urol; 2003 Jan; 169(1):352-6. PubMed ID: 12478188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.
    Qiu H; Kim MM; Penjweini R; Finlay JC; Busch TM; Wang T; Guo W; Cengel KA; Simone CB; Glatstein E; Zhu TC
    Photochem Photobiol; 2017 Jul; 93(4):1115-1122. PubMed ID: 28083883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy combined with photofrin or 5-ALA: effect on Lewis sarcoma tumor lines implanted in mice. Preliminary results.
    Schaffer M; Schaffer PM; Jori G; Corti L; Sotti G; Hofstetter A; Dühmke E
    Tumori; 2002; 88(5):407-10. PubMed ID: 12487560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy of early squamous cell cancers of the esophagus.
    Radu A; Wagnières G; van den Bergh H; Monnier P
    Gastrointest Endosc Clin N Am; 2000 Jul; 10(3):439-60. PubMed ID: 10900053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.
    Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA
    Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy with systemic administration of photosensitizers in dermatology.
    Calzavara-Pinton PG; Szeimies RM; Ortel B; Zane C
    J Photochem Photobiol B; 1996 Nov; 36(2):225-31. PubMed ID: 9002266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy.
    Dougherty TJ
    Photochem Photobiol; 1993 Dec; 58(6):895-900. PubMed ID: 8310013
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcellular localization of Photofrin and aminolevulinic acid and photodynamic cross-resistance in vitro in radiation-induced fibrosarcoma cells sensitive or resistant to photofrin-mediated photodynamic therapy.
    Wilson BC; Olivo M; Singh G
    Photochem Photobiol; 1997 Jan; 65(1):166-76. PubMed ID: 9066298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
    Lilge L; Wilson BC
    J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett's oesophagus.
    Dunn JM; Mackenzie GD; Banks MR; Mosse CA; Haidry R; Green S; Thorpe S; Rodriguez-Justo M; Winstanley A; Novelli MR; Bown SG; Lovat LB
    Lasers Med Sci; 2013 May; 28(3):707-15. PubMed ID: 22699800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
    Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG
    Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Penjweini R; Kim MM; Ong YH; Zhu TC
    Phys Med Biol; 2020 Jan; 65(3):03LT01. PubMed ID: 31751964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photofrin photodynamic therapy: 2.0 mg/kg or not 2.0 mg/kg that is the question.
    Allison RR; Sibata CH
    Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):112-9. PubMed ID: 19356641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin.
    Henderson BW; Vaughan L; Bellnier DA; van Leengoed H; Johnson PG; Oseroff AR
    Photochem Photobiol; 1995 Oct; 62(4):780-9. PubMed ID: 7480155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of drug-light interval on the mode of action of Photofrin photodynamic therapy in a mouse tumor model.
    Li LB; Luo RC
    Lasers Med Sci; 2009 Jul; 24(4):597-603. PubMed ID: 18936869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
    Sitnik TM; Henderson BW
    Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model.
    Cheung R; Solonenko M; Busch TM; Del Piero F; Putt ME; Hahn SM; Yodh AG
    J Biomed Opt; 2003 Apr; 8(2):248-52. PubMed ID: 12683850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical aminolevulinic acid-photodynamic therapy in the treatment of keratoacanthoma: A case report.
    Lv T; Miao F; Wu MF; Nie S; Li SS; Wang XL; Wang HW
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():151-153. PubMed ID: 29913213
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro and in vivo photosensitizing applications of Photofrin in malignant melanoma cells.
    Chang CJ; Yu JS; Wei FC
    Chang Gung Med J; 2008; 31(3):260-7. PubMed ID: 18782948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.